MSI Financial Services
BIB icon

MSI Financial Services’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

MSI Financial Services’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4K Hold
100
– – ﹤0.01% 3216
2016
Q3 		$5K Hold
100
– – ﹤0.01% 3115
2016
Q2 		$4K Hold
100
– – ﹤0.01% 3225
2016
Q1 		$4K Hold
100
– – ﹤0.01% 3235
2015
Q4 		$7K Buy
+100
New +$6.68K ﹤0.01% 2890
2014
Q3 		– Sell
-600
Closed -$28K – 2638
2014
Q2 		$28K Buy
+600
New +$23.7K ﹤0.01% 1340

Other funds holding BIB

RIA
RPG Investment Advisory Pleasanton, California $973M AUM 39.93% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
TH
Timber Hill Greenwich, Connecticut $15.4M AUM 30.7% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Virtu KCG Holdings
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

MSI Financial Services's BIB Position: Q4 2016 in Review

MSI Financial Services held its ProShares Ultra NASDAQ Biotechnology (BIB) position steady in Q4 2016 at 100 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3216.

MSI Financial Services first reported a position in BIB in Q2 2014 and has held it in 6 quarters since. The position peaked at $28K in Q2 2014. 31 funds tracked by Wall St. Rank hold BIB as of Q4 2016.

  • MSI Financial Services held 100 shares of ProShares Ultra NASDAQ Biotechnology worth $4K as of Q4 2016.
  • MSI Financial Services left its ProShares Ultra NASDAQ Biotechnology share count unchanged in Q4 2016.
  • ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3216 holding.
  • MSI Financial Services first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2014 and has held it in 6 quarters since.
  • MSI Financial Services's ProShares Ultra NASDAQ Biotechnology position peaked at $28K in Q2 2014.
  • 31 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.